Spots Global Cancer Trial Database for reolysin
Every month we try and update this database with for reolysin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma | NCT00998322 | Metastatic Panc... | REOLYSIN Gemcitabine | 18 Years - | Oncolytics Biotech | |
| A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer | NCT01656538 | Metastatic Brea... | Paclitaxel Reolysin | 18 Years - | Canadian Cancer Trials Group | |
| Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma | NCT03015922 | Multiple Myelom... | Lenalidomide or... REOLYSIN | 18 Years - | University of Leeds | |
| Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers | NCT01166542 | Carcinoma, Squa... | REOLYSIN Carboplatin Paclitaxel Placebo | 18 Years - | Oncolytics Biotech | |
| REO13 Melanoma With of Without GM-CSF | NCT03282188 | Melanoma Cancer of Skin | Reolysin GM-CSF | 18 Years - | University of Leeds | |
| A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma | NCT00998322 | Metastatic Panc... | REOLYSIN Gemcitabine | 18 Years - | Oncolytics Biotech | |
| A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer | NCT01656538 | Metastatic Brea... | Paclitaxel Reolysin | 18 Years - | Canadian Cancer Trials Group | |
| A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung | NCT00998192 | Metastatic or R... | REOLYSIN Paclitaxel Carboplatin | 18 Years - | Oncolytics Biotech | |
| Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma | NCT00984464 | Metastatic Mela... | REOLYSIN Carboplatin Paclitaxel | 18 Years - | Oncolytics Biotech | |
| Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma | NCT03015922 | Multiple Myelom... | Lenalidomide or... REOLYSIN | 18 Years - | University of Leeds | |
| A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung | NCT00998192 | Metastatic or R... | REOLYSIN Paclitaxel Carboplatin | 18 Years - | Oncolytics Biotech | |
| Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma | NCT03015922 | Multiple Myelom... | Lenalidomide or... REOLYSIN | 18 Years - | University of Leeds | |
| Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation | NCT00861627 | Carcinoma, Non-... | REOLYSIN® Carboplatin Paclitaxel | 18 Years - | Oncolytics Biotech | |
| Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers | NCT01166542 | Carcinoma, Squa... | REOLYSIN Carboplatin Paclitaxel Placebo | 18 Years - | Oncolytics Biotech | |
| Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma | NCT00753038 | Carcinoma, Squa... | REOLYSIN® Carboplatin Paclitaxel | 18 Years - | Oncolytics Biotech |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
